The role of glycosylation in the action of IGFBP-3

Progress in Growth Factor Research

Volumn 6, Issue 2-4, 1995, Pages 223-229

  Firth, Sue M ^a   Baxter, Robert C ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

binding; IGFBP 3; mutagenesis; N glycosylation

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL; ARTICLE; CHO CELL; GENETICS; GLYCOSYLATION; HAMSTER; HUMAN; METABOLISM; MOLECULAR WEIGHT; SITE DIRECTED MUTAGENESIS;

ANIMALS; CARRIER PROTEINS; CHO CELLS; CRICETINAE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MOLECULAR WEIGHT; MUTAGENESIS, SITE-DIRECTED; SOMATOMEDINS;

EID: 0029433606     PISSN: 09552235     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2235(95)00009-7     Document Type: Article

References (30)

1. r 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling
2. Insulin-Like Growth Factor (IGF) Binding Proteins: the Role of Serum IGFBPs in Regulating IGF Availability
3. Insulin-like growth factor binding protein-3: biochemistry and physiology
4. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts
5. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism
6. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
7. Transfection of the human IGFBP-3 gene into BALB/c fibroblasts—a model for the cellular functions of IGFBPs
8. Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the ‘150-K’ complex during pregnancy
9. Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-I
10. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness
11. Insulin-like growth factor binding protein-3 proteolysis is induced after elective surgery
12. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex
13. Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum
14. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF-I administration and in extrapancreatic tumor hypoglycemia
15. Identification of the major sites of phosphorylation in IGF binding protein-3
16. Identification and mutagenesis of putative phosphorylation sites on IGFBP-3
17. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein
18. A protocol for using T7 DNA polymerase in oligonucleotide site-directed mutagenesis
19. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase
20. High-frequency transfection of CHO cells using polybrene
21. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
22. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3
23. Purification and characterization of human recombinant insulin-like growth factor binding protein 3 expressed in Chinese hamster ovary cells
24. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3
25. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3)
26. Protein glycosylation. Structural and functional aspects
27. Insulin-like growth factor binding protein-3: factors affecting binary and ternary complex formation.
28. Insulin-like growth factor-I (IGF-I) and transforming growth factor-β1 release IGF-binding protein-3 from human fibroblasts by different mechanisms
29. Modulation of human IGF binding protein-3 activity by structural modification
30. Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I